SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors.
SOHM, Inc. acquired ABBIE, a disruptive gene-editing platform, from CGA 369 in September 2023 for \(\$10\) million. The technology specializes in targeted genomic integration and non-viral vector payload delivery
Explore More
